Keyword

SER-109

Description: An investigational oral microbiome therapy consisting of purified bacterial spores, developed to prevent recurrent Clostridioides difficile infection.
Wikidata ID: wiki/Q118113233
OpenAlex ID: keywords/ser-109
2022 · Paul Feuerstadt, Thomas J. Louie, et al. · New England Journal of Medicine · 626
2016 · Sahil Khanna, Darrell S. Pardi, et al. · The Journal of Infectious Diseases · 353
2017 · John P. Mills, Krishna Rao, et al. · Current Opinion in Gastroenterology · 193
2023 · Anne J. Gonzales-Luna, Travis J. Carlson, et al. · Gut Microbes · 71
2016 · Jessica Martin, Mark Wilcox · Current Opinion in Infectious Diseases · 50
2023 · Nicolas Benech, Frédéric Barbut, et al. · Clinical Microbiology and Infection · 36
2024 · Herbert L. DuPont, Andrew W. DuPont, et al. · Therapeutic Advances in Gastroenterology · 31
2024 · Abdelrahman Yakout, Yan Bi, et al. · Journal of Primary Care & Community Health · 18
2026 · Jessica A. Bryant, Marin Vulić, et al. · Nature Medicine · 13
Works count: 112
Citation count: 2,422
Year
Topic
Type